PX-1: A COMPREHENSIVE BUYER’S GUIDE

Regarding the detection techniques, immunoassay assessments for that screening of specific SCs are commercially readily available but need to have affirmation by LC-MS/MS and have become swiftly out of date, as shown by Franz and Many others [sixty]. The speedy development of new SCs is usually a limitation even for focused mass spectrometry screen